| # | Drug | Count |
|---|---|---|
| 0 | TEMOZOLOMIDE | 35 |
| 1 | LEVETIRACETAM | 20 |
| 2 | BEVACIZUMAB | 12 |
| 3 | DABRAFENIB | 10 |
| 4 | METHOTREXATE SODIUM | 10 |
| 5 | METHOTREXATE | 9 |
| 6 | LEVETIRACETAM IN SODIUM CHLORIDE | 8 |
| 7 | LEVETIRACETAM INJECTION | 8 |
| 8 | LEVETIRACETAM ORAL | 8 |
| 9 | SOMATROPIN | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LOMUSTINE | 5 | 0.0019 |
| 1 | TEMOZOLOMIDE | 35 | 0.0016 |
| 2 | DACTINOMYCIN | 3 | 0.0014 |
| 3 | CICLOPIROX | 3 | 0.0012 |
| 4 | LAROTRECTINIB | 1 | 0.0011 |
| 5 | NORETHINDRONE AND ETHINYL ESTRADIOL | 1 | 0.0009 |
| 6 | PENTAMIDINE ISETHIONATE | 1 | 0.0008 |
| 7 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 8 | ADENOSINE | 1 | 0.0006 |
| 9 | DABRAFENIB | 10 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 3 | 0.0014 |
| 1 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Recombinant Human Growth Hormone [EPC] | 5 | 0.0002 |
| 3 | Melatonin Receptor Agonist [EPC] | 3 | 0.0002 |
| 4 | Alkylating Drug [EPC] | 43 | 0.0002 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 6 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 7 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 9 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |